epigenomics
Sitemap Search Glossary Contact FAQs Deutsch
Directors' Dealings

As a result of the implementation of the 4th Financial Markets Promotion Act (4. Finanzmarkt- förderungsgesetz), §15a of the German Securities Trading Act (Wertpapierhandelsgesetz) became effective on 1 July 2002. Under these acts the reporting of certain securities transactions is legally mandated. Moreover, these transactions also have to be published without delay on the issuer's homepage for a period of one month.

Members of the
Executive Board
Owned shares
as of January 31,
2008
Stock options
as of January 31,
2008
Excercised
options
in 2007
Geert Walther Nygaard
Chief Executive Officer
Berlin (D)
20,000 180,000 0
Dr. Kurt Berlin
Chief Scientific Officer
Stahnsdorf (D)
114,750 146,613 0
Christian Piepenbrock
Chief Information Officer
Berlin (D)
117,300 146,613 0
Oliver Schacht
Chief Financial Officer
Seattle, WA (U.S.A.)
117,050 159,363 0
     
Members of the
Supervisory Board
Owned shares
as of January 31,
2008
Stock options
as of January 31,
2008
 
Excercised
options
in 2007
 
Ann Clare Kessler
Rancho Santa Fe, CA (U.S.A.)
14,000 

 

Declared Securities Transactions in Current Fiscal Year
(Transaction in previous fiscal years are found here)

Members of the
Executive Board
Date Type Amount
of shares
BAFin
Oliver Schacht
Chief Financial Officer
Seattle, WA (U.S.A.)
28.01.2008 buy 12,500 PDF-file
150 kb
Geert Walther Nygaard
Chief Executive Officer
Berlin (D)
29.01.2008  buy 20,000   PDF-file 
76 kb
         
Members of the
Supervisory Board
Date Type Amount
of shares
BAFin
Ann Clare Kessler
Rancho Santa Fe, CA (U.S.A.)
25.01.2008 buy 14,000 PDF-file
153 kB


top of the page